Literature DB >> 8952542

High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells.

S Di Paolo1, L Gesualdo, E Ranieri, G Grandaliano, F P Schena.   

Abstract

High glucose concentration has been shown to induce the overexpression of transforming growth factor (TGF)-beta 1 mRNA and protein in different cell types, including murine mesangial cells, thus possibly accounting for the expansion of mesangial extracellular matrix observed in diabetic glomerulopathy. In the present study, we evaluated platelet-derived growth factor (PDGF) B-chain and PDGF-beta receptor gene expression in human mesangial cells (HMCs) exposed to different concentrations of glucose and then sought a possible relationship between a PDGF loop and the modulation of TGF-beta 1 expression. HMC [3H]thymidine incorporation was upregulated by 30 mmol/L glucose (HG) up to 24 hours, whereas it was significantly inhibited at later time points. Neutralizing antibodies to PDGF BB abolished the biphasic response to HG, whereas anti-TGF-beta antibodies reversed only the late inhibitory effect of hyperglycemic medium. HG induced an early and persistent increase of PDGF B-chain gene expression, as evaluated by reverse transcriptase polymerase chain reaction, whereas PDGF-beta receptor mRNA increased by twofold after 6 hours, thereafter declining at levels 70% lower than in controls after 24 hours. 125I-Labeled PDGF BB binding studies in HMCs exposed to HG for 24 hours confirmed the decrease of PDGF-beta receptor expression. TGF-beta 1-specific transcripts showed 43 and 78% increases after 24 and 48 hours of incubation in HG, respectively, which was markedly diminished by anti-PDGF BB neutralizing antibodies or suramin. We conclude that HG induces an early activation of a PDGF loop that, in turn, causes an increase of TGF-beta 1 gene expression, thus modulating both HMC proliferation and mesangial matrix production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952542      PMCID: PMC1865344     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

Review 1.  Mesangial cell turnover: effect of heparin and peptide growth factors.

Authors:  L J Striker; E P Peten; S J Elliot; T Doi; G E Striker
Journal:  Lab Invest       Date:  1991-04       Impact factor: 5.662

2.  Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF.

Authors:  A Knecht; L G Fine; K S Kleinman; H P Rodemann; G A Müller; D D Woo; J T Norman
Journal:  Am J Physiol       Date:  1991-08

3.  Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit.

Authors:  T Coimbra; R Wiggins; J W Noh; S Merritt; S H Phan
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

Review 4.  The transforming growth factor-beta family.

Authors:  J Massagué
Journal:  Annu Rev Cell Biol       Date:  1990

5.  Regulation of mesangial cell growth by polypeptide mitogens. Inhibitory role of transforming growth factor beta.

Authors:  F Jaffer; C Saunders; P Shultz; D Throckmorton; E Weinshell; H E Abboud
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

Review 6.  Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients.

Authors:  M W Steffes; R Osterby; B Chavers; S M Mauer
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

7.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.

Authors:  S Okuda; L R Languino; E Ruoslahti; W A Border
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

8.  TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop.

Authors:  E J Battegay; E W Raines; R A Seifert; D F Bowen-Pope; R Ross
Journal:  Cell       Date:  1990-11-02       Impact factor: 41.582

9.  Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.

Authors:  H Iida; R Seifert; C E Alpers; R G Gronwald; P E Phillips; P Pritzl; K Gordon; A M Gown; R Ross; D F Bowen-Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

10.  Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.

Authors:  W A Border; S Okuda; L R Languino; M B Sporn; E Ruoslahti
Journal:  Nature       Date:  1990-07-26       Impact factor: 49.962

View more
  30 in total

Review 1.  Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.

Authors:  G Pugliese; F Pricci; G Romeo; G Leto; L Amadio; C Iacobini; U Di Mario
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1.

Authors:  M H Poczatek; C Hugo; V Darley-Usmar; J E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

3.  Deletion of platelet-derived growth factor receptor-β improves diabetic nephropathy in Ca²⁺/calmodulin-dependent protein kinase IIα (Thr286Asp) transgenic mice.

Authors:  H Suzuki; I Usui; I Kato; T Oya; Y Kanatani; Y Yamazaki; S Fujisaka; S Senda; Y Ishii; M Urakaze; A Mahmood; S Takasawa; H Okamoto; M Kobayashi; K Tobe; M Sasahara
Journal:  Diabetologia       Date:  2011-08-11       Impact factor: 10.122

4.  In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.

Authors:  Hang Wang; Jianmin Wang; Hua Qu; Huili Wei; Baolan Ji; Zesong Yang; Jing Wu; Qin He; Yuanyuan Luo; Dan Liu; Yang Duan; Fang Liu; Huacong Deng
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

5.  CCN3: a novel anti-fibrotic treatment in end-stage renal disease?

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2012-03-16       Impact factor: 5.782

6.  Dextrose injections for failed back surgery syndrome: a consecutive case series.

Authors:  İlker Solmaz; Serkan Akpancar; Aydan Örsçelik; Özlem Yener-Karasimav; Deniz Gül
Journal:  Eur Spine J       Date:  2019-05-21       Impact factor: 3.134

Review 7.  Prolotherapy: Potential for the Treatment of Chronic Wounds?

Authors:  Amir Hossein Siadat; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-04-03       Impact factor: 4.730

8.  Effects of multiple injections of hypertonic dextrose in the rabbit carpal tunnel: a potential model of carpal tunnel syndrome development.

Authors:  Yuichi Yoshii; Chunfeng Zhao; James D Schmelzer; Phillip A Low; Kai-Nan An; Peter C Amadio
Journal:  Hand (N Y)       Date:  2014-03

9.  C-peptide reverses TGF-beta1-induced changes in renal proximal tubular cells: implications for treatment of diabetic nephropathy.

Authors:  Claire E Hills; Nawal Al-Rasheed; Nouf Al-Rasheed; Gary B Willars; Nigel J Brunskill
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-17

10.  Lack of type VIII collagen in mice ameliorates diabetic nephropathy.

Authors:  Ulrike Hopfer; Helmut Hopfer; Catherine Meyer-Schwesinger; Ivonne Loeffler; Naomi Fukai; Bjorn R Olsen; Rolf A K Stahl; Gunter Wolf
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.